Carisma Therapeutics, Inc.
CARM
$0.2153
$0.00180.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.48M | -63.80M | -72.50M | -81.22M | -86.88M |
| Total Depreciation and Amortization | 3.35M | 3.41M | 3.37M | 3.83M | 2.84M |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 1.28M |
| Total Other Non-Cash Items | 9.16M | 10.60M | 10.63M | 8.18M | 7.02M |
| Change in Net Operating Assets | -11.95M | -17.87M | -17.14M | -8.86M | -5.44M |
| Cash from Operations | -59.92M | -67.66M | -75.64M | -78.07M | -81.18M |
| Capital Expenditure | -123.00K | -684.00K | -873.00K | -1.01M | -1.13M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 11.00M | 41.00M | 77.00M | 73.54M |
| Cash from Investing | -123.00K | 10.32M | 40.13M | 75.99M | 72.41M |
| Total Debt Issued | 686.00K | 686.00K | 849.00K | 777.00K | 1.18M |
| Total Debt Repaid | -2.74M | -2.73M | -3.62M | -3.84M | -2.37M |
| Issuance of Common Stock | 2.42M | 3.11M | 3.02M | 3.07M | 31.42M |
| Repurchase of Common Stock | -23.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -758.00K | -4.22M | 31.94M |
| Cash from Financing | 344.00K | 1.07M | -507.00K | -4.21M | 62.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.70M | -56.28M | -36.02M | -6.29M | 53.41M |